Frost & Sullivan Press releases 1 - 10 of 77 Press ReleasesMar 13, 2012 Emergence of Innovative Treatment Options to Support Improved Compliance and Enhanced Therapeutic Results Mar 06, 2012 Investments from local operators fuelling growth in the private hospitals sector Feb 23, 2012 The rise in disease incidence rate boosts demand for innovative therapeutics Feb 20, 2012 Enhanced efficiency, need for regulatory compliance and improved safety and control capabilities will be key to sustaining growth The Patent Expiry of Blockbuster Biologics to Create Opportunities in the European Biosimilar Market Feb 15, 2012 Seamlessly Integrated R&D, Production, Sales and Marketing Processes to Ensure Success in this High Growth Market Feb 13, 2012 Focus on innovative, high quality yet cost-effective products will be critical to promoting long-term growth Feb 06, 2012 Market growth is expected to reach $487.4 million in 2015 – Tech-savvy customers are demanding superior yet cost efficient test equipment Feb 01, 2012 Increasing Incidence of Thrombosis, Paralleled by Maturing Life cycles of Existing Products, Underpin the Demand for Novel Alternatives Jan 30, 2012 New Government Regulations Mandating the Maintenance of Archives Bodes Well for the PACS Market Jan 23, 2012 High Initial Costs and Concerns over Quality Dim Market Prospects, but Revenues Expected to Reach $1.92 Billion in 2018 |